China Kanghui Holdings, a Chinese maker of orthopedic implants, has filed for a $75 million IPO. It plans to trade on the NYSE under ticker symbol KH, with Morgan Stanley and Piper Jaffray serving as co-lead underwriters.
Shareholders include IDG-Accel (21.5% pre-IPO stake), SIG China Investments (18.4%), TDF Capital (12.4%) and CDH Venture Capital (9%).
Take your pick!
- Buyouts delivers exclusive news and analysis about private equity deals, fundraising, top-quartile managers and more. Get your FREE trial or subscribe now.
- VC Journal provides exclusive news and analysis about venture capital deals, fundraising, top-quartile investors and more. Get your FREE trial or subscribe now.